Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic markers in well differentiated papillary and follicular thyroid cancer (WDTC)
Sarah Louise Gillanders, James P. O’Neill
European Journal of Surgical Oncology (2017) Vol. 44, Iss. 3, pp. 286-296
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Risk Stratification in Differentiated Thyroid Cancer: From Detection to Final Follow-Up
R. Michael Tuttle, Ali S. Alzahrani
The Journal of Clinical Endocrinology & Metabolism (2019) Vol. 104, Iss. 9, pp. 4087-4100
Open Access | Times Cited: 130
Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies
Mohamed Aashiq, Deborah A. Silverman, Shorook Na’ara, et al.
Cancers (2019) Vol. 11, Iss. 9, pp. 1382-1382
Open Access | Times Cited: 128
Thyroid nodules: diagnostic evaluation based on thyroid cancer risk assessment
Naykky Singh Ospina, Nicole M. Iñiguez‐Ariza, M. Regina Castro
BMJ (2020), pp. l6670-l6670
Closed Access | Times Cited: 107
Increased expression of GPX4 promotes the tumorigenesis of thyroid cancer by inhibiting ferroptosis and predicts poor clinical outcomes
Huanjie Chen, Fang Peng, Jingchao Xu, et al.
Aging (2023) Vol. 15, Iss. 1, pp. 230-245
Open Access | Times Cited: 22
From biomarkers to therapeutic targets: the promise of PD-L1 in thyroid autoimmunity and cancer
Grégoire D’Andréa, Sandra Lassalle, N. Guevara, et al.
Theranostics (2020) Vol. 11, Iss. 3, pp. 1310-1325
Open Access | Times Cited: 37
Long-Term Outcome of Differentiated Thyroid Cancer Patients—Fifty Years of Croatian Thyroid Disease Referral Centre Experience
Tomislav Jukić, Ivan Blažeković, Maja Franceschi, et al.
Diagnostics (2022) Vol. 12, Iss. 4, pp. 866-866
Open Access | Times Cited: 18
The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice
Krzysztof Kaliszewski, Dorota Diakowska, Łukasz Nowak, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 24
Risk factors for death of follicular thyroid carcinoma: a systematic review and meta-analysis
Ting Zhang, Liang He, Zhihong Wang, et al.
Endocrine (2023) Vol. 82, Iss. 3, pp. 457-466
Open Access | Times Cited: 8
Whole-Exome Sequencing Identifies Two Discrete Druggable Signaling Pathways in Follicular Thyroid Cancer
Neeta J. Erinjeri, Norman G. Nicolson, Michael K. Deyholos, et al.
Journal of the American College of Surgeons (2018) Vol. 226, Iss. 6, pp. 950-959e5
Closed Access | Times Cited: 24
Programmed Cell Death–Ligand 1 Overexpression in Thyroid Cancer
Guo-Qiang Zhang, Weijun Wei, Hong-Jun Song, et al.
Endocrine Practice (2019) Vol. 25, Iss. 3, pp. 279-286
Closed Access | Times Cited: 23
Resveratrol Inhibits the Tumorigenesis of Follicular Thyroid Cancer via ST6GAL2-Regulated Activation of the Hippo Signaling Pathway
Gaoran Xu, Jun-zhu Chen, Guorong Wang, et al.
Molecular Therapy — Oncolytics (2020) Vol. 16, pp. 124-133
Open Access | Times Cited: 23
Plant natural products with anti-thyroid cancer activity
Javad Sharifi‐Rad, Sadegh Rajabi, Miquel Martorell, et al.
Fitoterapia (2020) Vol. 146, pp. 104640-104640
Closed Access | Times Cited: 23
Long non‑coding RNA H19 knockdown inhibits the cell viability and promotes apoptosis of thyroid cancer cells through regulating the PI3K/AKT pathway
Xiaoyu Li, Qinghuai Li, Xiao Jin, et al.
Experimental and Therapeutic Medicine (2019)
Open Access | Times Cited: 22
The Antitumour Effect of Prunella vulgaris Extract on Thyroid Cancer Cells In Vitro and In Vivo
Fangqin Yu, Lele Zhang, Runsheng Ma, et al.
Evidence-based Complementary and Alternative Medicine (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 15
Androgen Activity Is Associated With PD-L1 Downregulation in Thyroid Cancer
Timmy J. O’Connell, Sina Dadafarin, Melanie Jones, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 15
The efficacy of radioactive iodine for the treatment of well-differentiated thyroid cancer with distant metastasis
Jen‐Der Lin, Sheng‐Fong Kuo, Bie-Yui Huang, et al.
Nuclear Medicine Communications (2018) Vol. 39, Iss. 12, pp. 1091-1096
Open Access | Times Cited: 18
MiR-19a Overexpression in FTC-133 Cell Line Induces a More De-Differentiated and Aggressive Phenotype
Giovanna Calabrese, Anna Dolcimascolo, Filippo Torrisi, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 12, pp. 3944-3944
Open Access | Times Cited: 18
Papillary Thyroid Micro Carcinoma: The Incidence of High-Risk Features and Its Prognostic Implications
Rui Gao, Xi Jia, Yiqian Liang, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 15
Routine thyroglobulin, neck ultrasound and physical examination in the routine follow up of patients with differentiated thyroid cancer—Where is the evidence?
Jessica L. Gray, Gautam K. Singh, Lesley Uttley, et al.
Endocrine (2018) Vol. 62, Iss. 1, pp. 26-33
Open Access | Times Cited: 14
Radioactive iodine refractoriness in Middle Eastern differentiated thyroid cancer: clinical outcome and risk factor analysis
Sandeep Kumar Parvathareddy, Abdul K Siraj, Nabil Siraj, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1
The role of preoperative serum thyroglobulin in the diagnosis and treatment of differentiated thyroid cancer: a systematic review and meta-analysis
Ying Lu, Hao Zhao, C.-Y. Liu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Long non-coding RNA signatures as predictors of prognosis in thyroid cancer: a narrative review
Hongyuan Zhao, Cristabelle De Souza, Vigneshwari Easwar Kumar, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 4, pp. 359-359
Open Access | Times Cited: 10
A Novel Role of Galectin-3 and Thyroglobulin in Prognosis and Differentiation of Different Stages of Thyroid Cancer and Elucidation of the Potential Contribution of Bcl-2, IL-8 and TNF-α
Tarek M. Okda, Gamal M. K. Atwa, Ahmed Fathy Eldehn, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 352-352
Open Access | Times Cited: 7
Significance and management of incidentally diagnosed metastatic papillary thyroid carcinoma in cervical lymph nodes in neck dissection specimens
Magis Mandapathil, Paul Lennon, Ian Ganly, et al.
Head & Neck (2019) Vol. 41, Iss. 11, pp. 3783-3787
Closed Access | Times Cited: 10
Dynamic Risk Stratification for Predicting Treatment Response in Differentiated Thyroid Cancer
Evanthia Giannoula, Christos Melidis, Nikitas Papadopoulos, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2708-2708
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top